Bioceres Crop Solutions Corp (BIOX)

$12.42

+0.06

(+0.49%)

Market is closed - opens 8 PM, 05 Dec 2023

Insights on Bioceres Crop Solutions Corp

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 93.60M → 116.6M (in $), with an average increase of 10.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 28.14M → -4.6M (in $), with an average decrease of 67.3% per quarter

Performance

  • $12.28
    $12.49
    $12.42
    downward going graph

    1.13%

    Downside

    Day's Volatility :1.68%

    Upside

    0.56%

    downward going graph
  • $9.76
    $14.20
    $12.42
    downward going graph

    21.42%

    Downside

    52 Weeks Volatility :31.27%

    Upside

    12.54%

    downward going graph

Returns

PeriodBioceres Crop Solutions CorpSector (Materials)Index (Russel 2000)
3 Months
5.01%
-0.6%
0.0%
6 Months
-3.21%
6.1%
0.0%
1 Year
-4.26%
-0.5%
-6.5%
3 Years
117.22%
16.1%
-6.5%

Highlights

Market Capitalization
766.1M
Book Value
$4.76
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
0.22
PE Ratio
55.45
Wall Street Target Price
21.2
Profit Margin
3.35%
Operating Margin TTM
3.35%
Return On Assets TTM
3.14%
Return On Equity TTM
4.19%
Revenue TTM
408.9M
Revenue Per Share TTM
6.52
Quarterly Revenue Growth YOY
-8.1%
Gross Profit TTM
178.0M
EBITDA
56.3M
Diluted Eps TTM
0.22
Quarterly Earnings Growth YOY
-0.61
EPS Estimate Current Year
0.38
EPS Estimate Next Year
0.72
EPS Estimate Current Quarter
0.06
EPS Estimate Next Quarter
0.1

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Bioceres Crop Solutions Corp(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 70.69%

Current $12.42
Target $21.20

Company Financials

FY17Y/Y Change
Revenue
133.5M
↑ 42.46%
Net Income
-11.0M
↓ 6.59%
Net Profit Margin
-8.27%
↑ 4.34%
FY18Y/Y Change
Revenue
160.3M
↑ 20.09%
Net Income
-16.4M
↑ 48.18%
Net Profit Margin
-10.2%
↓ 1.93%
FY19Y/Y Change
Revenue
160.3M
↑ 0.0%
Net Income
-16.4M
↑ 0.0%
Net Profit Margin
-10.2%
↑ 0.0%
FY20Y/Y Change
Revenue
172.4M
↑ 7.51%
Net Income
3.4M
↓ 120.53%
Net Profit Margin
1.95%
↑ 12.15%
FY21Y/Y Change
Revenue
206.7M
↑ 19.93%
Net Income
-3.8M
↓ 213.74%
Net Profit Margin
-1.85%
↓ 3.8%
FY22Y/Y Change
Revenue
328.5M
↑ 58.91%
Net Income
-3.9M
↑ 2.31%
Net Profit Margin
-1.19%
↑ 0.66%
Q2 FY22Q/Q Change
Revenue
126.8M
↑ 85.9%
Net Income
3.9M
↓ 156.07%
Net Profit Margin
3.08%
↑ 13.31%
Q3 FY22Q/Q Change
Revenue
105.7M
↓ 16.63%
Net Income
-4.7M
↓ 219.61%
Net Profit Margin
-4.42%
↓ 7.5%
Q4 FY22Q/Q Change
Revenue
94.5M
↓ 10.59%
Net Income
-8.4M
↑ 80.08%
Net Profit Margin
-8.91%
↓ 4.49%
Q1 FY23Q/Q Change
Revenue
93.6M
↓ 1.0%
Net Income
28.1M
↓ 434.02%
Net Profit Margin
30.07%
↑ 38.98%
Q2 FY23Q/Q Change
Revenue
104.7M
↑ 11.85%
Net Income
-3.8M
↓ 113.5%
Net Profit Margin
-3.63%
↓ 33.7%
Q3 FY23Q/Q Change
Revenue
116.6M
↑ 11.37%
Net Income
-4.6M
↑ 21.05%
Net Profit Margin
-3.95%
↓ 0.32%
FY17Y/Y Change
Total Assets
196.6M
↓ 18.02%
Total Liabilities
163.5M
↑ 2.11%
FY18Y/Y Change
Total Assets
242.5M
↑ 23.31%
Total Liabilities
180.4M
↑ 10.32%
FY19Y/Y Change
Total Assets
242.5M
↑ 0.0%
Total Liabilities
180.4M
↑ 0.0%
FY20Y/Y Change
Total Assets
297.6M
↑ 22.72%
Total Liabilities
236.8M
↑ 31.29%
FY21Y/Y Change
Total Assets
394.6M
↑ 32.61%
Total Liabilities
304.3M
↑ 28.5%
FY22Y/Y Change
Total Assets
518.2M
↑ 31.33%
Total Liabilities
359.9M
↑ 18.28%
Q2 FY22Q/Q Change
Total Assets
785.3M
↑ 55.94%
Total Liabilities
470.5M
↑ 21.72%
Q3 FY22Q/Q Change
Total Assets
518.2M
↓ 34.01%
Total Liabilities
359.9M
↓ 23.5%
Q4 FY22Q/Q Change
Total Assets
872.9M
↑ 68.43%
Total Liabilities
566.2M
↑ 57.32%
Q1 FY23Q/Q Change
Total Assets
845.9M
↓ 3.09%
Total Liabilities
511.6M
↓ 9.65%
Q2 FY23Q/Q Change
Total Assets
824.1M
↓ 2.57%
Total Liabilities
494.0M
↓ 3.44%
Q3 FY23Q/Q Change
Total Assets
840.7M
↑ 2.01%
Total Liabilities
507.6M
↑ 2.75%
FY17Y/Y Change
Operating Cash Flow
18.4M
↓ 3.74%
Investing Cash Flow
-8.2M
↓ 59.23%
Financing Cash Flow
-10.5M
↓ 548.29%
FY18Y/Y Change
Operating Cash Flow
29.7M
↑ 61.5%
Investing Cash Flow
-3.3M
↓ 60.33%
Financing Cash Flow
-26.9M
↑ 157.67%
FY19Y/Y Change
Operating Cash Flow
29.7M
↑ 0.0%
Investing Cash Flow
-22.2M
↑ 581.18%
Financing Cash Flow
-26.9M
↑ 0.0%
FY20Y/Y Change
Operating Cash Flow
11.4M
↓ 61.54%
Investing Cash Flow
-8.3M
↓ 62.59%
Financing Cash Flow
33.5M
↓ 224.44%
FY21Y/Y Change
Operating Cash Flow
-6.2M
↓ 154.34%
Investing Cash Flow
2.9M
↓ 134.93%
Financing Cash Flow
7.4M
↓ 78.06%
Q1 FY22Q/Q Change
Operating Cash Flow
7.8M
↓ 156.56%
Investing Cash Flow
-1.4M
-
Financing Cash Flow
-4.5M
↓ 135.34%
Q2 FY22Q/Q Change
Operating Cash Flow
-32.4M
↓ 516.99%
Investing Cash Flow
-1.4M
↑ 0.0%
Financing Cash Flow
40.2M
↓ 985.36%
Q3 FY22Q/Q Change
Operating Cash Flow
-5.4M
↓ 83.28%
Investing Cash Flow
3.0M
↓ 318.86%
Financing Cash Flow
1.6M
↓ 96.05%

Technicals Summary

Sell

Neutral

Buy

Bioceres Crop Solutions Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bioceres Crop Solutions Corp
Bioceres Crop Solutions Corp
16.06%
-3.21%
-4.26%
117.22%
22.38%
Nutrien Ltd.
Nutrien Ltd.
3.4%
0.54%
-29.2%
9.87%
8.67%
Corteva, Inc.
Corteva, Inc.
-7.54%
-17.79%
-28.22%
19.53%
59.31%
Cf Industries Holdings, Inc.
Cf Industries Holdings, Inc.
-3.64%
19.5%
-26.26%
92.85%
79.34%
Icl Israel Chemicals Ltd
Icl Israel Chemicals Ltd
6.21%
-8.06%
-40.0%
10.56%
-7.9%
Mosaic Company, The
Mosaic Company, The
13.61%
11.01%
-23.43%
61.98%
4.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bioceres Crop Solutions Corp
Bioceres Crop Solutions Corp
55.45
55.45
NA
0.38
0.04
0.03
0.0
4.76
Nutrien Ltd.
Nutrien Ltd.
12.53
12.53
NA
4.8
0.09
0.06
0.04
50.85
Corteva, Inc.
Corteva, Inc.
29.23
29.23
1.31
2.61
0.04
0.03
0.01
35.79
Cf Industries Holdings, Inc.
Cf Industries Holdings, Inc.
7.05
7.05
0.64
8.4
0.32
0.14
0.02
29.96
Icl Israel Chemicals Ltd
Icl Israel Chemicals Ltd
7.47
7.47
9.44
0.54
0.17
0.08
0.07
4.39
Mosaic Company, The
Mosaic Company, The
9.22
9.22
0.2
3.81
0.11
0.05
0.02
36.7
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bioceres Crop Solutions Corp
Bioceres Crop Solutions Corp
Buy
$766.1M
22.38%
55.45
3.35%
Nutrien Ltd.
Nutrien Ltd.
Buy
$27.3B
8.67%
12.53
7.34%
Corteva, Inc.
Corteva, Inc.
Buy
$32.3B
59.31%
29.23
5.38%
Cf Industries Holdings, Inc.
Cf Industries Holdings, Inc.
Buy
$14.5B
79.34%
7.05
27.53%
Icl Israel Chemicals Ltd
Icl Israel Chemicals Ltd
Hold
$6.7B
-7.9%
7.47
11.48%
Mosaic Company, The
Mosaic Company, The
Hold
$11.9B
4.59%
9.22
8.8%

Institutional Holdings

  • Solel Partners LP

    7.29%
  • Ardsley Advisory Partners

    2.95%
  • Uniplan Investment Counsel, Inc.

    0.75%
  • Arisaig Partners (Asia) Pte Ltd

    0.42%
  • Allianz Asset Management AG

    0.37%
  • Wellington Management Company LLP

    0.37%

Company Information

bioceres crop solutions corp., together with its subsidiaries, provides crop productivity solutions. the company operates through three segments: seed and integrated products, crop protection, and crop nutrition. the seed and integrated products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. the crop protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. the crop nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. in addition, the company offers hb4, a drought tolerant seed technology program. it operates in argentina, austria, bolivia, brazil, lebanon, the united states, italy, paraguay, the united kingdom, south africa, france, canada, ukraine, uruguay, and internationally. the company is headquartered in rosario, argentina. bioceres crop solutions corp. is a subsidiary of bioceres llc.

Organization
Bioceres Crop Solutions Corp
Employees
0
CEO
Jose A. Roque
Industry
Commercial Services

FAQs